In Vitro Transforming Potential, Intracellular Signaling Properties, and Sensitivity to a Kinase Inhibitor (Sorafenib) of Ret Proto-Oncogene Variants Glu511Lys, Ser649Leu, and Arg886Trp
AuthID
P-002-NY0
P-002-NY0